DHR logo

Danaher Corporation (DHR)

$242.05

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on DHR

Market cap

$170.97B

EPS

4.86

P/E ratio

48.2

Price to sales

6.82

Dividend yield

0.529%

Beta

0.898722

Price on DHR

Previous close

$234.33

Today's open

$235.34

Day's range

$234.29 - $242.22

52 week range

$171 - $258.23

Profile about DHR

CEO

Rainer M. Blair

Employees

63000

Headquarters

Washington, DC

Exchange

New York Stock Exchange

Shares outstanding

706349563

Issue type

Common Stock

DHR industries and sectors

Healthcare

Biotechnology & Life Sciences

News on DHR

Danaher (DHR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Danaher (DHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

news source

Zacks Investment Research • 21 hours ago

news preview

Danaher Corporation (DHR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Danaher Corporation (DHR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

news source

Seeking Alpha • Jan 13, 2026

news preview

Mar Vista U.S. Quality Q4 2025 Top Contributors And Detractors

Mar Vista's U.S. Quality strategy returned +0.20% net-of-fees in Q4 2025. The Russell 1000 Index and the S&P 500 Index returned +2.41% and +2.65%, respectively. Alphabet, Johnson & Johnson and Danaher Corp. were among the portfolio's top contributors for the quarter.

news source

Seeking Alpha • Jan 13, 2026

news preview

Danaher CEO to Comment on Financial Performance

WASHINGTON, Jan. 12, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment tomorrow on the Company's fourth quarter 2025 performance in a presentation at the J.P.

news source

PRNewsWire • Jan 12, 2026

news preview

The Lab Equipment Titan Trading at Half the Multiple Just Delivered Another Beat

Danaher (NYSE: DHR) and Thermo Fisher Scientific (NYSE: TMO) both reported Q3 2025 earnings showing revenue growth around 5%, but underlying business momentum tells very different stories.

news source

24/7 Wall Street • Jan 10, 2026

news preview

Danaher Is Ready to Put Its Post-Covid Malaise Behind It

With tariff rules finalized and inventories depleted, there's light at the end of the tunnel for the medical and scientific tools manufacturer.

news source

Barrons • Jan 8, 2026

news preview

The Big 3: BA, DHR, DG

Dan Deming offers a glimpse into companies outside the AI trade he sees rallying in 2026. He offers bullish perspective and example options trades for Boeing (BA), Danaher (DHR), and Dollar General (DG).

news preview

Danaher to Present at J.P. Morgan Healthcare Conference

WASHINGTON, Jan. 5, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that its President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P.

news source

PRNewsWire • Jan 5, 2026

news preview

Top 15 High-Growth Dividend Stocks For January 2026

My Top 15 High-Growth Dividend Stock list delivered a 0.83% gain in December, outperforming SPY and VIG. The Value-tilted portfolio variant led with a 2.17% December return, suggesting undervaluation may drive near-term alpha. Collectively, the January 2026 list offers a 1.35% yield, 16.87% five-year dividend growth, and appears 29% undervalued.

news source

Seeking Alpha • Jan 3, 2026

news preview

The Value Traps Of The REIT Sector

A low valuation is not enough in the REIT sector. Many of the cheapest REITs are also the worst investments. I highlight many REIT value traps to avoid going into 2026.

news source

Seeking Alpha • Dec 27, 2025

news preview

¹ Disclosures

Get started with M1

Invest in Danaher Corporation

Open an M1 investment account to buy and sell Danaher Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in DHR on M1